Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2011-04-19
2011-04-19
Kemmerer, Elizabeth C. (Department: 1646)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S007210, C435S007800
Reexamination Certificate
active
07927812
ABSTRACT:
The present invention relates to a method for diagnosing an advanced ischemic coronary heart disease comprising the steps of determining an amount of a cardiac troponin in a sample of a subject and diagnosing the disease by comparing the amount determined with a reference amount of the cardiac troponin.
REFERENCES:
patent: 5744305 (1998-04-01), Fodor et al.
patent: 2006/0234304 (2006-10-01), Amann-Zalan et al.
patent: 2428460 (2003-11-01), None
patent: 0648228 (1995-04-01), None
patent: 1363128 (2003-11-01), None
patent: 02/083913 (2002-10-01), None
patent: 02/089657 (2002-11-01), None
patent: 2004/103150 (2004-12-01), None
patent: 2005/043169 (2005-05-01), None
Al-Mallah,M. et al., “Positive Troponin in Diabetic Ketoacidosis without Acute Coronary Syndrome Predicts Poor Outcome,” Circulation, 110,17. Suppl. S (Oct. 2004) 413.
Anderson, P. et al., “Molecular Basis of Human Cardiac Troponin T Isoforms Expressed in the Developing, Adult, and Falling Heart,” Circulation Research, 76:4 (Apr. 1995) 681-686.
Bonow, R. et al., “New Insights into the Cardiac Natriuretic Peptides,” Circulation, 93 (1996) 1946-1950.
DeFilippi, C. et al., “Cardiac Troponin I and C-Reactive Protein for Predicting Prognosis, Coronary Atheroscierosis, and Cardiomyopathy in Patients Undergoing Long-Term Hemodialysis,” JAMA, 290;3 (Jul. 16, 2003) 353-359.
Ferrieres, G. et al., “Human Cardiac Troponin I: Precise Identification of Antigenic Epitopes and Prediction of Secondary Structure,” Clinical Chemistry, 44;3 (1998) 487-493.
Hojs, R. et al., “Cardiac Troponin (T) in Hemodialysis Patients with Asymptomatic and Symptomatic Atherosclerosis,” Archives of Medical Research 36 (2005) 367-371.
Karl, J. et al., “Development of a Novel, N-Terminal- proBNP (NT-proBNP) Assay with a Low Detection Limit,” Scand J Clin Lab Invest, 59(suppl 230) (1999) 177-181.
Mueller, T. et al., “Long-term stability of endogenous B-type natriuretic peptide (BP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples,” Clin Chem Lab MED, 42;8 (2004) 942-944.
Nolan, J. et al., “Suspension array technology: evolution of the flat-array paradigm,” Trends in Biotechnology, 20, 1 (Jan. 2002) 9-12.
Smith, M, et al., “Delayed Metabolism of Human Brain Natriuretic Peptide Reflects Resistance to Neutral Endopeptidase,” Journal of Endocrinology, 167 (2000) 239-246.Clinical Chemistry, 50:5 (2004) 867-873.
Wu, A. et al., “Analytical and Clinical Evaluation of the Bayer ADVIA Centaur Automated B-Type Natriuretic Peptide Assay in Patients with Heart Failure A Multisite Study,” Clinical Chemistry, 50:5 (2004) 867-873.
Yeo, K, et al., “Multicenter Evaluation of the Roche NT-proBNP Assay and Comparison to the Biosite Triage BNP Assay,” Clinica Chimica Acta, 338 (2003) 107-115.
Zethelius, B. et al., “Troponin I as a Predictor of Coronary Heart Disease and Mortality in 70-Year-Old Men,” Circulation 113:8 (Feb. 28, 2006) 1071-1078.
“Myocardial Infarction Redefined-A Consensus Document of the Joint European Society of Cardiology/American College of Cardology Committee for the Redefinition of Myocardial Infarction,” Journal of the American College of Cardiology, 36;3 (2000) 959-969.
Hess Andrea
Hess Georg
Kemmerer Elizabeth C.
Roche Diagnostics Operations Inc.
LandOfFree
Cardiac troponin as an indicator of coronary artery disease does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cardiac troponin as an indicator of coronary artery disease, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cardiac troponin as an indicator of coronary artery disease will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2683126